HomeFinancial Aid for Macular Degeneration Medications
Fact Sheet

Financial Aid for Macular Degeneration Medications

Sunday, July 5, 2015

Learn about financial aid resources that may be available to help cover the costs of your macular degeneration prescription medications.

Macular Degeneration Medications

(On mobile devices, swipe left to see all of the table columns.)

Medication NameGenericDrug CompanyToll-Free Number
Eylea™AfliberceptRegeneron1-855-EYLEA-4U
Lucentis®RanibizumabGenentech1-866-4-ACCESS
Macugen®

Pegaptanib Sodium

Eyetech1-866-272-8838
Visudyne®VerteporfinNovartis1-800-245-5356

 

Financial Aid Helpful Resources

(On mobile devices, swipe left to see all of the table columns.)

OrganizationProgramPhone Number
Partnership for Prescription AssistancePrescription Assistance Service1-888-477-2669
TogetherONETogether Rx Access1-800-444-4106
RxHopePatient Assistance Programs1-877-267-0517
MAP InternationalMedical Supply Program

1-800-225-8550

MedicarePrescription Drug Plans1-800-633-4227

 

 

This content was last updated on: Saturday, August 29, 2015

Disease:

Macular Degeneration
Disease Stage:
Treatment
Topic:
Drugs & Medication, Financial & Legal Matters

The information provided is a public service of the BrightFocus Foundation and is not intended to constitute medical advice. It should not in any way substitute for the advice of a qualified healthcare professional. Please consult your physician for personalized medical advice; all medications and supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical product or therapy.

Share this:

Facebook Twitter Google Plus Email
Print this page

More Like This

  • Fact Sheet

    Clinical Trial Information for Macular Degeneration

    It can take many years for a potential treatment for macular degeneration to work its way from the laboratory, through rigorous testing and, finally, to become approved by the U.S. Food and Drug Administration (FDA). Learn more about the process and how clinical trials work.

    Tuesday, June 20, 2017
  • Fact Sheet

    Macular Degeneration: Frequently Asked Questions

    Age-related macular degeneration (AMD) is a common eye disease that causes deterioration of the macula, the central area of the retina. Read the answers to the most frequently asked questions about this eye disease.

    Thursday, June 8, 2017
  • Fact Sheet

    Best Practices for Healthy Vision

    Many factors impact the health of the human eye. Even if disease is already present, following these recommendations can help your body be its healthiest and, in some cases, slow the progression of the disease.

    Friday, April 14, 2017

Don't miss out.
Receive research updates, inspiring stories, and expert advice
Keep me imformed about: *
Please select at least one.
You must select at least one disease category.
Please enter your first name.
Please enter your last name.

Join us in the fight to end brain and eye disease

  • As many as 11 million people in the United States have some form of age-related macular degeneration. This number is expected to double to nearly 22 million by 2050.

  • We're the leading nonprofit funder of research for the advanced form of macular degeneration. 

  • Global Impact

    BrightFocus makes innovative science possible around the world—1,380 research projects involving more than 4,140 scientists in 22 countries.

  • You can make a difference. 
    Support macular degeneration research to help find a cure.

    Give Now

Is this a new diagnosis?

The first few weeks after a diagnosis can be overwhelming, and leave you with many questions and concerns.

If you are managing a new diagnosis, we have a Getting Started Guide that will help you understand and manage your disease.

Yes, go to the Getting Started Guide
No, return to the Toolkit